Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts.
Open Access
- 1 November 1996
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 98 (9) , 2042-2049
- https://doi.org/10.1172/jci119009
Abstract
Bradykinin (BK), a pluripotent nonameric peptide, is known for its proinflammatory functions in both tissue injury and allergic inflammation of the airway mucosa and submucosa. To understand the mechanisms by which BK serves as an inflammatory mediator, the human lung fibroblast cell line WI-38 was stimulated with BK and the expression of IL-1beta gene was examined. BK at nanomolar concentrations induced a marked increase in immunoreactive IL-1beta, detectable within 2 h in both secreted and cell-associated forms. BK-induced IL-1beta synthesis was inhibited by a B2-type BK receptor antagonist and by treatment of the cells with pertussis toxin, indicating the involvement of a BK receptor that couples to the G(i)/G(o) class of heterotrimeric G proteins. Whereas cycloheximide and actinomycin D both inhibited BK-induced IL-1beta synthesis, results from Northern blot and nuclear run-on assays suggested that BK acted primarily at the transcription level which led to the accumulation of IL-1beta message in stimulated cells. Gel mobility shift assays were used with nuclear extracts from stimulated WI-38 cells to examine the transcription mechanism for BK-induced IL-1beta expression. A DNA binding activity specific for the decameric kappaB enhancer was detected and was found to contain the p50 and p65 subunits of the NF-kappaB/rel protein family. BK-induced NF-kappaB activation correlated with IL-1beta message upregulation with respect to agonist concentration, time course, sensitivity to bacterial toxins, and blockade by the B2 receptor antagonist. After BK stimulation, a significant increase in the activity of chloramphenicol acetyltransferase was observed in WI-38 cells transfected with a reporter plasmid bearing the kappaB enhancers from the IL-1beta gene. Deletion of the kappaB enhancer sequence significantly reduced BK-induced chloramphenicol acetyltransferase activity. These findings suggests a novel function of BK in the activation of NF-kappaB and the induction of cytokine gene expression.Keywords
This publication has 42 references indexed in Scilit:
- Release of cytokines from isolated lung strips by bradykininInflammation Research, 1995
- Involvement of NF-κB Activation in Thrombin-Induced Human Vascular Smooth Muscle Cell ProliferationBiochemical and Biophysical Research Communications, 1994
- B2 Bradykinin Receptors in NG108-15 Cells: cDNA Cloning and Functional ExpressionBiochemical and Biophysical Research Communications, 1994
- B1 and B2 Bradykinin Receptors Encoded by Distinct mRNAsJournal of Neurochemistry, 1994
- The G proteins of the G alpha i and G alpha q family couple the bradykinin receptor to the release of endothelium-derived relaxing factor.Journal of Clinical Investigation, 1993
- Bradykinin and inflammatory painTrends in Neurosciences, 1993
- Biochemical and Molecular Pharmacology of Kinin ReceptorsAnnual Review of Pharmacology and Toxicology, 1992
- Cloning and pharmacological characterization of a human bradykinin (BK-2) receptorBiochemical and Biophysical Research Communications, 1992
- Expression of Functional Bradykinin Receptors in Xenopus OocytesJournal of Neurochemistry, 1992
- Kinin Formation: Mechanisms and Role in Inflammatory DisordersAnnual Review of Immunology, 1988